HEMATOLOGICAL RECOVERY AFTER HIGH-DOSE CYCLOPHOSPHAMIDE (CTX) AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)

被引：0
|
作者：
TWELVES, CJ
SOUHAMI, RL
HARPER, PG
GOLDSTONE, A
机构：
[1] GUYS HOSP, CLIN ONCOL UNIT, LONDON SE1 9RT, ENGLAND
[2] UNIV COLL HOSP LONDON, DEPT ONCOL, LONDON WC 1, ENGLAND
[3] UNIV COLL HOSP LONDON, DEPT HAEMATOL, LONDON WC 1, ENGLAND
来源：
BRITISH JOURNAL OF CANCER | 1988年 / 58卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：276 / 277
页数：2
相关论文
共 50 条
  • [31] ACUTE TRANSIENT PAROTITIS AFTER HIGH-DOSE ETOPOSIDE AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    CRUMP, M
    BRANDWEIN, JM
    SCOTT, JG
    SUTCLIFFE, SB
    KEATING, A
    BONE MARROW TRANSPLANTATION, 1990, 6 (04) : 259 - 261
  • [32] WHEN IS AUTOLOGOUS BONE-MARROW TRANSPLANTATION SAFE AFTER HIGH-DOSE TREATMENT WITH ETOPOSIDE
    LITTLEWOOD, TJ
    SPRAGG, BP
    BENTLEY, DP
    CLINICAL AND LABORATORY HAEMATOLOGY, 1985, 7 (03): : 213 - 218
  • [33] HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED HODGKINS-DISEASE
    JAGANNATH, S
    DICKE, KA
    ARMITAGE, JO
    CABANILLAS, FF
    HORWITZ, LJ
    VELLEKOOP, L
    ZANDER, AR
    SPITZER, G
    ANNALS OF INTERNAL MEDICINE, 1986, 104 (02) : 163 - 168
  • [34] HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN POOR PROGNOSIS NON-HODGKINS LYMPHOMAS (NHL)
    LAMAGNERE, JP
    COLOMBAT, P
    BINET, C
    DESBOIS, I
    BABAULT, C
    CALAIS, G
    REISENLEITER, M
    DOMENECH, J
    BONE MARROW TRANSPLANTATION, 1988, 3 : 82 - 82
  • [35] HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN PREVIOUSLY UNTREATED NON-HODGKINS-LYMPHOMA
    TURA, S
    MAZZA, P
    GHERLINZONI, F
    RICCI, P
    VISANI, G
    BANDINI, G
    ZACCARIA, A
    ROSTI, G
    LAURIA, F
    BACCARANI, M
    ZINZANI, PL
    POLETTI, G
    MOTTA, MR
    RIZZI, S
    VERLICCHI, F
    FINELLI, C
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1986, 37 (04): : 347 - 352
  • [36] FACTORS INFLUENCING ENGRAFTMENT AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
    VANBESIEN, K
    NICHOLS, CR
    TRICOT, GJ
    AKARD, L
    JANSEN, J
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 487 - 487
  • [37] AUTOLOGOUS BONE-MARROW TRANSPLANTATION - HOST EFFECTS OF HIGH-DOSE BCNU
    TAKVORIAN, T
    PARKER, LM
    HOCHBERG, FH
    CANELLOS, GP
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (10) : 610 - 620
  • [38] HIGH-DOSE IMMUNOGLOBULIN TREATMENT IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION ]BMT)
    LAMBERTENGHIDELILIERS, G
    BENAZZI, E
    MOZZANA, R
    ZOCCHI, L
    POLLI, EE
    INTERNATIONAL JOURNAL OF CELL CLONING, 1985, 3 (04): : 272 - 273
  • [39] HIGH-DOSE CHEMOTHERAPY WITHOUT AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN MELANOMA
    TCHEKMEDYIAN, NS
    TAIT, N
    VANECHO, D
    AISNER, J
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (12) : 1811 - 1818
  • [40] EARLY SIGNS OF RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
    HECHT, T
    HENKE, M
    WEITZMANN, U
    BROSS, K
    LOHR, GW
    BLUT, 1988, 57 (04): : 266 - 266
12345